Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 107666
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107666
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107666
Figure 1 Patient selection and study design.
GEO: Gene Expression Omnibus; HCs: Healthy controls; PBC: Primary biliary cholangitis; UDCA: Ursodeoxycholic acid; TNFAIP3: Tumor necrosis factor alpha-induced protein 3.
- Citation: Zang B, Li JX, Liu QX, Yao Y, Li H, Wang Y, Wang JG, Yang YF, Liang RW, Xin XR, Liu B. Tumor necrosis factor alpha-induced protein 3: A key biomarker for response to ursodeoxycholic acid in primary biliary cholangitis. World J Hepatol 2025; 17(7): 107666
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/107666.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.107666